Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Ion-Pair-Directed Borylation of Aromatic Phosphonium Salts.

Lee B, Mihai MT, Stojalnikova V, Phipps RJ.

J Org Chem. 2019 Jun 4. doi: 10.1021/acs.joc.9b00878. [Epub ahead of print]

PMID:
31117572
2.

Recent Advances in Minisci-Type Reactions.

Proctor RSJ, Phipps RJ.

Angew Chem Int Ed Engl. 2019 Mar 19. doi: 10.1002/anie.201900977. [Epub ahead of print]

PMID:
30888102
3.

Site-Selective Cross-Coupling of Remote Chlorides Enabled by Electrostatically Directed Palladium Catalysis.

Golding WA, Pearce-Higgins R, Phipps RJ.

J Am Chem Soc. 2018 Oct 24;140(42):13570-13574. doi: 10.1021/jacs.8b08686. Epub 2018 Oct 10.

PMID:
30295472
4.

Catalytic enantioselective Minisci-type addition to heteroarenes.

Proctor RSJ, Davis HJ, Phipps RJ.

Science. 2018 Apr 27;360(6387):419-422. doi: 10.1126/science.aar6376. Epub 2018 Apr 5.

PMID:
29622723
5.

Access to the meta position of arenes through transition metal catalysed C-H bond functionalisation: a focus on metals other than palladium.

Mihai MT, Genov GR, Phipps RJ.

Chem Soc Rev. 2018 Jan 2;47(1):149-171. doi: 10.1039/c7cs00637c. Review.

PMID:
29071326
6.

meta-Selective C-H Borylation of Benzylamine-, Phenethylamine-, and Phenylpropylamine-Derived Amides Enabled by a Single Anionic Ligand.

Davis HJ, Genov GR, Phipps RJ.

Angew Chem Int Ed Engl. 2017 Oct 16;56(43):13351-13355. doi: 10.1002/anie.201708967. Epub 2017 Sep 19.

7.

Highlights from the 52nd EUCHEM conference on stereochemistry, Bürgenstock, Switzerland, May 2017.

Montenegro J, Phipps RJ.

Chem Commun (Camb). 2017 Sep 5;53(72):9960-9966. doi: 10.1039/c7cc90258a. No abstract available.

PMID:
28837191
8.

Harnessing non-covalent interactions to exert control over regioselectivity and site-selectivity in catalytic reactions.

Davis HJ, Phipps RJ.

Chem Sci. 2017 Feb 1;8(2):864-877. doi: 10.1039/c6sc04157d. Epub 2016 Oct 5.

9.
10.

Ion Pair-Directed Regiocontrol in Transition-Metal Catalysis: A Meta-Selective C-H Borylation of Aromatic Quaternary Ammonium Salts.

Davis HJ, Mihai MT, Phipps RJ.

J Am Chem Soc. 2016 Oct 5;138(39):12759-12762. Epub 2016 Sep 21.

11.

Synthetic cannabinoid drug use as a cause or contributory cause of death.

Labay LM, Caruso JL, Gilson TP, Phipps RJ, Knight LD, Lemos NP, McIntyre IM, Stoppacher R, Tormos LM, Wiens AL, Williams E, Logan BK.

Forensic Sci Int. 2016 Mar;260:31-39. doi: 10.1016/j.forsciint.2015.12.046. Epub 2016 Jan 7.

PMID:
26795398
12.

Advances in catalytic enantioselective fluorination, mono-, di-, and trifluoromethylation, and trifluoromethylthiolation reactions.

Yang X, Wu T, Phipps RJ, Toste FD.

Chem Rev. 2015 Jan 28;115(2):826-70. doi: 10.1021/cr500277b. Epub 2014 Oct 22. Review. No abstract available.

13.

Gram-scale enantioselective formal synthesis of morphine through an ortho-para oxidative phenolic coupling strategy.

Tissot M, Phipps RJ, Lucas C, Leon RM, Pace RD, Ngouansavanh T, Gaunt MJ.

Angew Chem Int Ed Engl. 2014 Dec 1;53(49):13498-501. doi: 10.1002/anie.201408435. Epub 2014 Oct 6.

PMID:
25288124
14.
15.

A combination of directing groups and chiral anion phase-transfer catalysis for enantioselective fluorination of alkenes.

Wu J, Wang YM, Drljevic A, Rauniyar V, Phipps RJ, Toste FD.

Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13729-33. doi: 10.1073/pnas.1304346110. Epub 2013 Aug 6.

16.

Chiral anion phase-transfer catalysis applied to the direct enantioselective fluorinative dearomatization of phenols.

Phipps RJ, Toste FD.

J Am Chem Soc. 2013 Jan 30;135(4):1268-71. doi: 10.1021/ja311798q. Epub 2013 Jan 18.

PMID:
23330962
17.

Fourier transform infrared imaging as a tool to chemically and spatially characterize matrix-mineral deposition in osteoblasts.

Faillace ME, Phipps RJ, Miller LM.

Calcif Tissue Int. 2013 Jan;92(1):50-8. doi: 10.1007/s00223-012-9667-5. Epub 2012 Nov 10.

PMID:
23143076
18.

A doubly axially chiral phosphoric acid catalyst for the asymmetric tandem oxyfluorination of enamides.

Honjo T, Phipps RJ, Rauniyar V, Toste FD.

Angew Chem Int Ed Engl. 2012 Sep 17;51(38):9684-8. doi: 10.1002/anie.201205383. Epub 2012 Aug 29. No abstract available.

PMID:
22930652
19.

The progression of chiral anions from concepts to applications in asymmetric catalysis.

Phipps RJ, Hamilton GL, Toste FD.

Nat Chem. 2012 Jul 24;4(8):603-14. doi: 10.1038/nchem.1405.

PMID:
22824891
20.

Bisphosphonates improve trabecular bone mass and normalize cortical thickness in ovariectomized, osteoblast connexin43 deficient mice.

Watkins MP, Norris JY, Grimston SK, Zhang X, Phipps RJ, Ebetino FH, Civitelli R.

Bone. 2012 Oct;51(4):787-94. doi: 10.1016/j.bone.2012.06.018. Epub 2012 Jun 29.

21.

Copper-catalyzed alkene arylation with diaryliodonium salts.

Phipps RJ, McMurray L, Ritter S, Duong HA, Gaunt MJ.

J Am Chem Soc. 2012 Jul 4;134(26):10773-6. doi: 10.1021/ja3039807. Epub 2012 Jun 19.

PMID:
22712572
22.

Asymmetric fluorination of enamides: access to α-fluoroimines using an anionic chiral phase-transfer catalyst.

Phipps RJ, Hiramatsu K, Toste FD.

J Am Chem Soc. 2012 May 23;134(20):8376-9. doi: 10.1021/ja303959p. Epub 2012 May 11.

PMID:
22574822
23.

Effects of alendronate and risedronate on bone material properties in actively forming trabecular bone surfaces.

Hofstetter B, Gamsjaeger S, Phipps RJ, Recker RR, Ebetino FH, Klaushofer K, Paschalis EP.

J Bone Miner Res. 2012 May;27(5):995-1003. doi: 10.1002/jbmr.1572.

24.

Increased strontium uptake in trabecular bone of ovariectomized calcium-deficient rats treated with strontium ranelate or strontium chloride.

Pemmer B, Hofstaetter JG, Meirer F, Smolek S, Wobrauschek P, Simon R, Fuchs RK, Allen MR, Condon KW, Reinwald S, Phipps RJ, Burr DB, Paschalis EP, Klaushofer K, Streli C, Roschger P.

J Synchrotron Radiat. 2011 Nov;18(Pt 6):835-41. doi: 10.1107/S090904951103038X. Epub 2011 Sep 15.

PMID:
21997907
25.

Bisphosphonates do not alter the rate of secondary mineralization.

Fuchs RK, Faillace ME, Allen MR, Phipps RJ, Miller LM, Burr DB.

Bone. 2011 Oct;49(4):701-5. doi: 10.1016/j.bone.2011.05.009. Epub 2011 May 18.

PMID:
21619951
26.

(±)-trans,cis-4-Hydroxy-5,6-di-O-isopropylidenecyclohex-2-ene-1-one: synthesis and facile dimerization to decahydrodibenzofurans.

Paddock VL, Phipps RJ, Conde-Angulo A, Blanco-Martin A, Giró-Mañas C, Martin LJ, White AJ, Spivey AC.

J Org Chem. 2011 Mar 4;76(5):1483-6. doi: 10.1021/jo102314w. Epub 2011 Jan 25.

PMID:
21265526
27.

A highly para-selective copper(II)-catalyzed direct arylation of aniline and phenol derivatives.

Ciana CL, Phipps RJ, Brandt JR, Meyer FM, Gaunt MJ.

Angew Chem Int Ed Engl. 2011 Jan 10;50(2):458-62. doi: 10.1002/anie.201004703. No abstract available.

PMID:
21140387
28.

Copper(II)-catalyzed meta-selective direct arylation of α-aryl carbonyl compounds.

Duong HA, Gilligan RE, Cooke ML, Phipps RJ, Gaunt MJ.

Angew Chem Int Ed Engl. 2011 Jan 10;50(2):463-6. doi: 10.1002/anie.201004704. Epub 2010 Oct 22. No abstract available.

PMID:
20967917
29.

Effect of risedronate on osteocyte viability and bone turnover in paired iliac bone biopsies from early postmenopausal women.

Qiu S, Phipps RJ, Ebetino FH, Palnitkar S, Sudhaker Rao D.

Calcif Tissue Int. 2010 Nov;87(5):392-7. doi: 10.1007/s00223-010-9411-y. Epub 2010 Aug 31.

PMID:
20809096
30.

Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate.

Allen MR, Turek JJ, Phipps RJ, Burr DB.

Bone. 2011 Jul;49(1):128-32. doi: 10.1016/j.bone.2010.07.011. Epub 2010 Jul 15.

PMID:
20637914
31.

MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1.

Chai G, Liu N, Ma J, Li H, Oblinger JL, Prahalad AK, Gong M, Chang LS, Wallace M, Muir D, Guha A, Phipps RJ, Hock JM, Yu X.

Cancer Sci. 2010 Sep;101(9):1997-2004. doi: 10.1111/j.1349-7006.2010.01616.x.

32.

Tissue distribution of newer anticonvulsant drugs in postmortem cases.

Levine B, Phipps RJ, Naso C, Fahie K, Fowler D.

J Anal Toxicol. 2010 Oct;34(8):506-9.

PMID:
21819796
33.

Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells.

Papanicolaou SE, Phipps RJ, Fyhrie DP, Genetos DC.

Biorheology. 2009;46(5):389-99. doi: 10.3233/BIR-2009-0550.

PMID:
19940355
34.

Differences between bisphosphonates in binding affinities for hydroxyapatite.

Lawson MA, Xia Z, Barnett BL, Triffitt JT, Phipps RJ, Dunford JE, Locklin RM, Ebetino FH, Russell RG.

J Biomed Mater Res B Appl Biomater. 2010 Jan;92(1):149-55. doi: 10.1002/jbm.b.31500.

PMID:
19904734
35.

Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading.

Feher A, Koivunemi A, Koivunemi M, Fuchs RK, Burr DB, Phipps RJ, Reinwald S, Allen MR.

Bone. 2010 Jan;46(1):203-7. doi: 10.1016/j.bone.2009.10.023. Epub 2009 Oct 24.

PMID:
19857619
36.

A meta-selective copper-catalyzed C-H bond arylation.

Phipps RJ, Gaunt MJ.

Science. 2009 Mar 20;323(5921):1593-7. doi: 10.1126/science.1169975.

37.

Effect of risedronate on bone mass, remodelling and biomechanical strength in orchidectomized rats.

Díaz-Curiel M, de la Piedra C, Romero FI, Montero M, Gómez S, Lefort M, Carrascal MT, Phipps RJ.

Horm Res. 2008;70(2):93-9. doi: 10.1159/000139151. Epub 2008 Jun 12.

PMID:
18547956
38.

Cu(II)-catalyzed direct and site-selective arylation of indoles under mild conditions.

Phipps RJ, Grimster NP, Gaunt MJ.

J Am Chem Soc. 2008 Jul 2;130(26):8172-4. doi: 10.1021/ja801767s. Epub 2008 Jun 11.

PMID:
18543910
39.

Recovery of trabecular and cortical bone turnover after discontinuation of risedronate and alendronate therapy in ovariectomized rats.

Fuchs RK, Phipps RJ, Burr DB.

J Bone Miner Res. 2008 Oct;23(10):1689-97. doi: 10.1359/jbmr.080501.

40.

Strontium ranelate does not stimulate bone formation in ovariectomized rats.

Fuchs RK, Allen MR, Condon KW, Reinwald S, Miller LM, McClenathan D, Keck B, Phipps RJ, Burr DB.

Osteoporos Int. 2008 Sep;19(9):1331-41. doi: 10.1007/s00198-008-0602-6. Epub 2008 Apr 3.

PMID:
18385919
41.

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.

Russell RG, Xia Z, Dunford JE, Oppermann U, Kwaasi A, Hulley PA, Kavanagh KL, Triffitt JT, Lundy MW, Phipps RJ, Barnett BL, Coxon FP, Rogers MJ, Watts NB, Ebetino FH.

Ann N Y Acad Sci. 2007 Nov;1117:209-57. Review.

PMID:
18056045
42.

Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolution in vitro.

Henneman ZJ, Nancollas GH, Ebetino FH, Russell RG, Phipps RJ.

J Biomed Mater Res A. 2008 Jun 15;85(4):993-1000.

43.

In situ examination of the time-course for secondary mineralization of Haversian bone using synchrotron Fourier transform infrared microspectroscopy.

Fuchs RK, Allen MR, Ruppel ME, Diab T, Phipps RJ, Miller LM, Burr DB.

Matrix Biol. 2008 Jan;27(1):34-41. Epub 2007 Jul 27.

PMID:
17884405
44.

Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading.

Follet H, Li J, Phipps RJ, Hui S, Condon K, Burr DB.

Bone. 2007 Apr;40(4):1172-7. Epub 2006 Dec 19.

PMID:
17240209
45.

Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia.

Iwata K, Li J, Follet H, Phipps RJ, Burr DB.

Bone. 2006 Nov;39(5):1053-1058. doi: 10.1016/j.bone.2006.05.006. Epub 2006 Jun 27.

PMID:
16807159
46.

Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac, Cdc42, and Rho GTPases.

Dunford JE, Rogers MJ, Ebetino FH, Phipps RJ, Coxon FP.

J Bone Miner Res. 2006 May;21(5):684-94.

47.

Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: sequential triple biopsy studies with micro-computed tomography.

Borah B, Dufresne TE, Ritman EL, Jorgensen SM, Liu S, Chmielewski PA, Phipps RJ, Zhou X, Sibonga JD, Turner RT.

Bone. 2006 Aug;39(2):345-52. Epub 2006 Mar 29.

PMID:
16571382
48.

Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.

Nancollas GH, Tang R, Phipps RJ, Henneman Z, Gulde S, Wu W, Mangood A, Russell RG, Ebetino FH.

Bone. 2006 May;38(5):617-27. Epub 2005 Jul 20.

PMID:
16046206
49.

The effect of risedronate on bone mineralization as measured by micro-computed tomography with synchrotron radiation: correlation to histomorphometric indices of turnover.

Borah B, Ritman EL, Dufresne TE, Jorgensen SM, Liu S, Sacha J, Phipps RJ, Turner RT.

Bone. 2005 Jul;37(1):1-9.

PMID:
15894527
50.

Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.

Otomo H, Sakai A, Ikeda S, Tanaka S, Ito M, Phipps RJ, Nakamura T.

J Bone Miner Metab. 2004;22(5):404-14.

PMID:
15316861

Supplemental Content

Loading ...
Support Center